retatrutide triple agonist A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Retatrutide: The first-in-class investigational triple
Pay in 4 interest-free payments of $7.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17













:max_bytes(150000):strip_icc()/PARENTS-ozempic-and-pregnancy-6dd2575749924d4b97c515daf1f5a1c1.jpg)














